Back to top

Image: Bigstock

ORIC Pharmaceuticals (ORIC) in Focus: Stock Moves 6.7% Higher

Read MoreHide Full Article

ORIC Pharmaceuticals, Inc. (ORIC - Free Report) was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $20.85 to $31.78 in the past one-month time frame
 
The company has seen a mixed track record when it comes to estimate revisions of four increase and one decrease over the past few weeks, while the Zacks Consensus Estimate for the current quarter remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

ORIC Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.  

Investors interested in the Medical - Biomedical and Genetics industry may consider ASLAN Pharmaceuticals Limited (ASLN - Free Report) , which has a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Legal Marijuana: An Investor’s Dream

Imagine getting in early on a young industry primed to skyrocket from $17.7 billion in 2019 to an expected $73.6 billion by 2027.  

Although marijuana stocks did better as the pandemic took hold than the market as a whole, they’ve been pushed down. This is exactly the right time to get in on selected strong companies at a fraction of their value before COVID struck. Zacks’ Special Report, Marijuana Moneymakers, reveals 10 exciting tickers for urgent consideration.

Download Marijuana Moneymakers FREE >>


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


ASLAN Pharmaceuticals Ltd. (ASLN) - free report >>

Oric Pharmaceuticals, Inc. (ORIC) - free report >>